Moderna, Inc.
MRNA
•Stock Analysis$27.16
+0.00 (+0.00%)• Live
Moderna, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Moderna, Inc.
Key Financial Metrics
for Moderna, Inc.
P/E Ratio
-3.19
Revenue Growth
-52.75%
EPS Growth
+24.88%
Market Cap
$10.73B
Dividend Yield
0.00%
Debt/Equity
0.07
ROIC
-33.11%
FCF Yield
-37.50%
View additional metrics
Valuation
P/B Ratio1.06
EV/Sales3.12
Financial Health
Current Ratio4.22
Return on Assets-26.42%
Analyst Recommendations
for Moderna, Inc.
25 analysts
Consensus: Hold
About
for Moderna, Inc.
Company Details
for Moderna, Inc.
Sector
Healthcare
Industry
Biotechnology
CEO
Stephane Bancel
Employees
5,800
Market Cap
10.50B
Exchange
NASDAQ Global Select
IPO Date
December 7, 2018
Website
www.modernatx.comCIK
0001682852
ISIN
US60770K1079
CUSIP
60770K107
Country
US
Balance Sheet
for Moderna, Inc.
Cash Flow Statement
for Moderna, Inc.
Income Statement
for Moderna, Inc.
News
No news available at the moment.